HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Mohammad M Al-Sanea Selected Research
Mohammad M Al-Sanea Research Topics
Disease
19
Neoplasms (Cancer)
12/2023 - 01/2015
4
Edema (Dropsy)
09/2023 - 01/2018
4
Breast Neoplasms (Breast Cancer)
12/2022 - 01/2018
3
Neoplasm Metastasis (Metastasis)
01/2022 - 01/2021
2
Inflammation (Inflammations)
09/2023 - 08/2023
2
Wounds and Injuries (Trauma)
11/2022 - 04/2022
2
Hepatocellular Carcinoma (Hepatoma)
02/2022 - 12/2020
2
Leukemia
01/2022 - 01/2015
2
Ulcer
01/2022 - 01/2018
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 08/2014
1
Rheumatoid Arthritis
09/2023
1
Atherosclerosis
09/2023
1
Parkinson Disease (Parkinson's Disease)
08/2023
1
Dementia (Dementias)
11/2022
1
Virus Diseases (Viral Diseases)
01/2022
1
Salmonella Infections (Salmonellosis)
11/2021
1
Renal Cell Carcinoma (Grawitz Tumor)
10/2021
1
Stomach Ulcer (Gastric Ulcer)
04/2021
1
Colorectal Neoplasms (Colorectal Cancer)
01/2021
1
Pancreatic Neoplasms (Pancreatic Cancer)
01/2021
1
Prostatic Neoplasms (Prostate Cancer)
12/2020
1
Necrosis
11/2020
1
Psoriatic Arthritis
05/2020
1
Chromosome Aberrations (Chromosome Abnormalities)
05/2020
1
Stomach Neoplasms (Stomach Cancer)
01/2020
Drug/Important Bio-Agent (IBA)
4
Carrageenan
IBA
09/2023 - 01/2018
3
Antioxidants
IBA
03/2023 - 12/2020
3
Antineoplastic Agents (Antineoplastics)
IBA
05/2022 - 12/2021
2
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
05/2022 - 01/2021
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
05/2022 - 04/2022
2
Type II DNA Topoisomerases (Topoisomerase II)
IBA
01/2022 - 01/2015
2
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
12/2021 - 10/2021
2
benzofuran
IBA
12/2021 - 05/2020
2
Carboxylic Acids
IBA
06/2021 - 05/2020
2
Protein Isoforms (Isoforms)
IBA
06/2021 - 05/2020
2
Phosphotransferases (Kinase)
IBA
01/2021 - 08/2014
1
Sorafenib (BAY 43-9006)
FDA Link
12/2023
1
Lipids
IBA
09/2023
1
Ligands
IBA
09/2023
1
Chitosan
IBA
08/2023
1
Alginates
IBA
08/2023
1
Lipopolysaccharides
IBA
08/2023
1
oleuropein
IBA
08/2023
1
Monoamine Oxidase (MAO)
IBA
08/2023
1
Oximes
IBA
08/2023
1
Hypoglycemic Agents (Hypoglycemics)
IBA
03/2023
1
Anti-Allergic Agents (Antiallergic Agents)
IBA
03/2023
1
Free Radical Scavengers
IBA
03/2023
1
Nanocapsules
IBA
12/2022
1
Aluminum
IBA
11/2022
1
Therapeutic Uses
IBA
11/2022
1
Luteolin
IBA
11/2022
1
orientin
IBA
11/2022
1
Collagen
IBA
11/2022
1
Triterpenes
IBA
05/2022
1
Transforming Growth Factor-beta Type I Receptor
IBA
04/2022
1
Enzymes
IBA
02/2022
1
NAD (NADH)
IBA
02/2022
1
Proteins (Proteins, Gene)
FDA Link
02/2022
1
Oxidoreductases (Dehydrogenase)
IBA
02/2022
1
quinone (benzoquinone)
IBA
02/2022
1
trioctyl phosphine oxide (TOPO)
IBA
01/2022
1
Poly(ADP-ribose) Polymerase Inhibitors
IBA
01/2022
1
Celecoxib (Celebrex)
FDA Link
01/2022
1
Benzoates (Benzoate)
IBA
01/2022
1
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
01/2022
1
Lim Kinases
IBA
01/2022
1
Dosage Forms (Dosage Form)
IBA
11/2021
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
11/2021
1
Superoxide Dismutase
IBA
11/2021
1
Glutathione Reductase (Glutathione-Disulfide Reductase)
IBA
11/2021
1
tivozanib
IBA
10/2021
1
Sulfonamides
IBA
06/2021
1
Sulfones
IBA
06/2021
1
Indomethacin (Indometacin)
FDA Link
Generic
04/2021
1
Cimetidine (Biomet)
FDA Link
Generic
04/2021
1
Ketones
IBA
01/2021
1
Isoenzymes
IBA
01/2021
1
Liposomes (Liposome)
IBA
01/2021
1
ErbB Receptors (EGF Receptor)
IBA
01/2021
1
3-acetylpyridine
IBA
01/2021
1
tetramethylpyrazine
IBA
01/2021
1
Propidium (Propidium Iodide)
IBA
01/2021
1
carbonic anhydrase XII
IBA
01/2021
1
Chalcones
IBA
01/2021
1
Complex Mixtures
IBA
01/2021
1
Tubulin
IBA
01/2021
1
Biomarkers (Surrogate Marker)
IBA
01/2021
1
Spirooxindoles
IBA
12/2020
1
Caspase 3 (Caspase-3)
IBA
11/2020
1
Proliferating Cell Nuclear Antigen (PCNA)
IBA
11/2020
1
Acids
IBA
05/2020
1
Carbonic Anhydrase Inhibitors
IBA
05/2020
1
Type 4 Cyclic Nucleotide Phosphodiesterases
IBA
05/2020
1
apremilast
IBA
05/2020
1
Aurora Kinases
IBA
01/2020
1
Mediator Complex
IBA
01/2020
Therapy/Procedure
5
Therapeutics
11/2022 - 01/2020
1
Chemoprevention
02/2022
1
Complementary Therapies (Alternative Medicine)
11/2021